Publications by authors named "Erica Maxine Lazarus"

There is limited data about bacterial STIs in MSM populations in sub-Saharan Africa. Our retrospective analysis used data from the HVTN 702 HIV vaccine clinical trial (October 2016 to July 2021). We evaluated multiple variables.

View Article and Find Full Text PDF

Unlabelled: Because sexual transmission of HIV occurs across mucosal membranes, understanding the immune responses of the genital mucosa to vaccines may contribute knowledge to finding an effective candidate HIV vaccine. We describe the uptake of rectal secretion, cervical secretion and seminal mucosal secretion sampling amongst volunteers in a Phase 1b HIV vaccine trial. Age at screening, gender, study site and the designation of the person conducting the informed consent procedure were collected for volunteers who screened for the HVTN 097 study.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Erica Maxine Lazarus"

  • - Erica Maxine Lazarus' recent research primarily focuses on sexually transmitted infections (STIs) and HIV vaccine trials, particularly within vulnerable populations such as men who have sex with men (MSM) in sub-Saharan Africa.
  • - In her 2023 article, she highlights a significant lack of data regarding bacterial STIs in MSM, utilizing data from the HVTN 702 HIV vaccine clinical trial to analyze various factors affecting this population.
  • - Another key study, conducted in 2015, examines the uptake of genital mucosal sampling in the HVTN 097 HIV vaccine trial, emphasizing the importance of understanding immune responses in the genital mucosa to improve HIV vaccine development.